“Commentary about Open-Label Randomized Controlled Study of Ivermectin in Mild to Moderate COVID-19”. IMC Journal of Medical Science, vol. 14, no. 2, Apr. 2021, pp. 67-68, https://doi.org/10.3329/imcjms.v14i2.52833.